Gastric lymphoma: the revolution of the past decade

Scand J Gastroenterol Suppl. 2002:(236):27-36. doi: 10.1080/003655202320621427.

Abstract

Background: Gastric MALT type lymphomas are distinct lymphomas that may develop after chronic antigenic stimulation caused by infection with Helicobacter pylori. An early antigen-dependent phase precedes the development of an antigen-independent phase.

Methods: Narrative review.

Results: The causative relationship between a chronic H. pylori infection and gastric MALT lymphomas has been based on epidemiological, histological, experimental and therapeutic studies. H. pylori eradication leads to a histological remission in +/- 70% of patients in early stage low-grade MALT lymphoma. There is no basis for therapeutic consequences in the case of persistent monoclonality. Full thickness invasion of the gastric wall and lymph node involvement and/or high-grade lymphoma denote the transition to an antigen-independent phase and calls for conventional treatment modalities. Molecular findings show a specific translocation in low-grade MALT lymphomas: t(11,18) and nuclear expression of bcl-10 that are highly indicative of the transition of the antigen-dependent into the antigen-independent phase. Other chromosomal and molecular findings are probably also involved.

Conclusion: The multistep pathogenesis of chronic H. pylori gastritis into low-grade gastric MALT lymphoma and tumour progression to a higher stage and grade are characterized by multiple molecular biological events. Antigen-dependency during the early phase of this malignancy is proven by the results of H. pylori eradication.

Publication types

  • Review

MeSH terms

  • Chronic Disease
  • Gastric Mucosa / immunology
  • Gastric Mucosa / pathology
  • Gastritis / complications
  • Gastritis / immunology
  • Gastritis / therapy
  • Gastroscopy
  • Helicobacter Infections* / complications
  • Helicobacter Infections* / immunology
  • Helicobacter Infections* / therapy
  • Helicobacter pylori*
  • Humans
  • Lymphoma, B-Cell, Marginal Zone* / etiology
  • Lymphoma, B-Cell, Marginal Zone* / immunology
  • Lymphoma, B-Cell, Marginal Zone* / therapy
  • Neoplasm Staging
  • Stomach Neoplasms* / etiology
  • Stomach Neoplasms* / immunology
  • Stomach Neoplasms* / therapy